 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biochemical function
|
binding
|
2 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Nat Immunol
2:248-254
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of the murine NK cell-activating receptor NKG2D at 1.95 A.
|
|
D.W.Wolan,
L.Teyton,
M.G.Rudolph,
B.Villmow,
S.Bauer,
D.H.Busch,
I.A.Wilson.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
NKG2D, a homodimeric lectin-like receptor, is a unique stimulatory molecule that
is found on natural killer cells,T cells and activated macrophages.The natural
ligands for murine NKG2D are distant major histocompatibility complex homologs,
retinoic acid early transcript (Rae1) and H-60 minor histocompatibility antigen.
The crystal structure of the extracellular region of murine NKG2D reveals close
homology with other C-type lectin receptors such as CD94, Ly49A, rat MBP-A and
CD69. However, the precise mode of dimeric assembly varies among these natural
killer receptors, as well as their surface topography and electrostatic
properties.The NKG2D structure provides the first structural insights into the
role and ligand specificity of this stimulatory receptor in the innate and
adaptive immune system.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2. Structure of the murine NKG2D homodimer. (a) Top
view looking down onto the proposed binding surface. (b) Side
view showing the NH[2] terminus at the bottom of the structure
that would connect to the membrane at the cell surface by a
stalk comprised of 16 residues. The dimer is formed primarily of
an extension of the first -sheet
( 1)
across the interface. Color-coding as for Fig. 1.
|
 |
Figure 4.
Figure 4. Comparison of disulfide bridges at the dimer
interfaces of NKG2D, CD94 and Ly49A. Color-coding as for Fig.
3. Cysteines are colored yellow (for carbon) and green (for
sulfur).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Macmillan Publishers Ltd:
Nat Immunol
(2001,
2,
248-254)
copyright 2001.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.D.Brenner,
S.King,
M.Przewoznik,
I.Wolters,
C.Adam,
G.W.Bornkamm,
D.H.Busch,
M.Röcken,
and
R.Mocikat
(2010).
Requirements for control of B-cell lymphoma by NK cells.
|
| |
Eur J Immunol, 40,
494-504.
|
 |
|
|
|
|
 |
C.E.Hughes,
A.Y.Pollitt,
J.Mori,
J.A.Eble,
M.G.Tomlinson,
J.H.Hartwig,
C.A.O'Callaghan,
K.Fütterer,
and
S.P.Watson
(2010).
CLEC-2 activates Syk through dimerization.
|
| |
Blood, 115,
2947-2955.
|
 |
|
|
|
|
 |
M.Champsaur,
and
L.L.Lanier
(2010).
Effect of NKG2D ligand expression on host immune responses.
|
| |
Immunol Rev, 235,
267-285.
|
 |
|
|
|
|
 |
P.L.Shaw,
A.N.Kirschner,
T.S.Jardetzky,
and
R.Longnecker
(2010).
Characteristics of Epstein-Barr virus envelope protein gp42.
|
| |
Virus Genes, 40,
307-319.
|
 |
|
|
|
|
 |
L.P.Frenzel,
Z.Abdullah,
A.K.Kriegeskorte,
R.Dieterich,
N.Lange,
D.H.Busch,
M.Krönke,
O.Utermöhlen,
J.Hescheler,
and
T.Sarić
(2009).
Role of natural-killer group 2 member D ligands and intercellular adhesion molecule 1 in natural killer cell-mediated lysis of murine embryonic stem cells and embryonic stem cell-derived cardiomyocytes.
|
| |
Stem Cells, 27,
307-316.
|
 |
|
|
|
|
 |
E.J.Petrie,
C.S.Clements,
J.Lin,
L.C.Sullivan,
D.Johnson,
T.Huyton,
A.Heroux,
H.L.Hoare,
T.Beddoe,
H.H.Reid,
M.C.Wilce,
A.G.Brooks,
and
J.Rossjohn
(2008).
CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence.
|
| |
J Exp Med, 205,
725-735.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.Y.Kwong,
S.Baskar,
H.Zhang,
C.L.Mackall,
and
C.Rader
(2008).
Generation, affinity maturation, and characterization of a human anti-human NKG2D monoclonal antibody with dual antagonistic and agonistic activity.
|
| |
J Mol Biol, 384,
1143-1156.
|
 |
|
|
|
|
 |
S.J.Burgess,
K.Maasho,
M.Masilamani,
S.Narayanan,
F.Borrego,
and
J.E.Coligan
(2008).
The NKG2D receptor: immunobiology and clinical implications.
|
| |
Immunol Res, 40,
18-34.
|
 |
|
|
|
|
 |
S.L.Rogers,
and
J.Kaufman
(2008).
High allelic polymorphism, moderate sequence diversity and diversifying selection for B-NK but not B-lec, the pair of lectin-like receptor genes in the chicken MHC.
|
| |
Immunogenetics, 60,
461-475.
|
 |
|
|
|
|
 |
L.C.Sullivan,
C.S.Clements,
T.Beddoe,
D.Johnson,
H.L.Hoare,
J.Lin,
T.Huyton,
E.J.Hopkins,
H.H.Reid,
M.C.Wilce,
J.Kabat,
F.Borrego,
J.E.Coligan,
J.Rossjohn,
and
A.G.Brooks
(2007).
The heterodimeric assembly of the CD94-NKG2 receptor family and implications for human leukocyte antigen-E recognition.
|
| |
Immunity, 27,
900-911.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.D.Coudert,
and
W.Held
(2006).
The role of the NKG2D receptor for tumor immunity.
|
| |
Semin Cancer Biol, 16,
333-343.
|
 |
|
|
|
|
 |
L.Deng,
and
R.A.Mariuzza
(2006).
Structural basis for recognition of MHC and MHC-like ligands by natural killer cell receptors.
|
| |
Semin Immunol, 18,
159-166.
|
 |
|
|
|
|
 |
M.G.Rudolph,
R.L.Stanfield,
and
I.A.Wilson
(2006).
How TCRs bind MHCs, peptides, and coreceptors.
|
| |
Annu Rev Immunol, 24,
419-466.
|
 |
|
|
|
|
 |
A.K.Kriegeskorte,
F.E.Gebhardt,
S.Porcellini,
M.Schiemann,
C.Stemberger,
T.J.Franz,
K.M.Huster,
L.N.Carayannopoulos,
W.M.Yokoyama,
M.Colonna,
A.G.Siccardi,
S.Bauer,
and
D.H.Busch
(2005).
NKG2D-independent suppression of T cell proliferation by H60 and MICA.
|
| |
Proc Natl Acad Sci U S A, 102,
11805-11810.
|
 |
|
|
|
|
 |
A.Krmpotic,
M.Hasan,
A.Loewendorf,
T.Saulig,
A.Halenius,
T.Lenac,
B.Polic,
I.Bubic,
A.Kriegeskorte,
E.Pernjak-Pugel,
M.Messerle,
H.Hengel,
D.H.Busch,
U.H.Koszinowski,
and
S.Jonjic
(2005).
NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145.
|
| |
J Exp Med, 201,
211-220.
|
 |
|
|
|
|
 |
A.N.Zelensky,
and
J.E.Gready
(2005).
The C-type lectin-like domain superfamily.
|
| |
FEBS J, 272,
6179-6217.
|
 |
|
|
|
|
 |
D.Garrity,
M.E.Call,
J.Feng,
and
K.W.Wucherpfennig
(2005).
The activating NKG2D receptor assembles in the membrane with two signaling dimers into a hexameric structure.
|
| |
Proc Natl Acad Sci U S A, 102,
7641-7646.
|
 |
|
|
|
|
 |
P.C.Saether,
I.H.Westgaard,
L.M.Flornes,
S.E.Hoelsbrekken,
J.C.Ryan,
S.Fossum,
and
E.Dissen
(2005).
Molecular cloning of KLRI1 and KLRI2, a novel pair of lectin-like natural killer-cell receptors with opposing signalling motifs.
|
| |
Immunogenetics, 56,
833-839.
|
 |
|
|
|
|
 |
R.Biassoni,
and
N.Dimasi
(2005).
Human natural killer cell receptor functions and their implication in diseases.
|
| |
Expert Rev Clin Immunol, 1,
405-417.
|
 |
|
|
|
|
 |
E.L.Cooper
(2004).
Commentary on CAM and NK Cells by Kazuyoshi Takeda and Ko Okumura.
|
| |
Evid Based Complement Alternat Med, 1,
29-34.
|
 |
|
|
|
|
 |
J.Koike,
H.Wakao,
Y.Ishizuka,
T.A.Sato,
M.Hamaoki,
K.Seino,
H.Koseki,
T.Nakayama,
and
M.Taniguchi
(2004).
Bone marrow allograft rejection mediated by a novel murine NK receptor, NKG2I.
|
| |
J Exp Med, 199,
137-144.
|
 |
|
|
|
|
 |
A.N.Zelensky,
and
J.E.Gready
(2003).
Comparative analysis of structural properties of the C-type-lectin-like domain (CTLD).
|
| |
Proteins, 52,
466-477.
|
 |
|
|
|
|
 |
B.J.McFarland,
and
R.K.Strong
(2003).
Thermodynamic analysis of degenerate recognition by the NKG2D immunoreceptor: not induced fit but rigid adaptation.
|
| |
Immunity, 19,
803-812.
|
 |
|
|
|
|
 |
D.H.Margulies
(2003).
Molecular interactions: stiff or floppy (or somewhere in between?).
|
| |
Immunity, 19,
772-774.
|
 |
|
|
|
|
 |
S.Radaev,
and
P.D.Sun
(2003).
Structure and function of natural killer cell surface receptors.
|
| |
Annu Rev Biophys Biomol Struct, 32,
93.
|
 |
|
|
|
|
 |
E.Vivier,
E.Tomasello,
and
P.Paul
(2002).
Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition?
|
| |
Curr Opin Immunol, 14,
306-311.
|
 |
|
|
|
|
 |
J.G.Luz,
M.Huang,
K.C.Garcia,
M.G.Rudolph,
V.Apostolopoulos,
L.Teyton,
and
I.A.Wilson
(2002).
Structural comparison of allogeneic and syngeneic T cell receptor-peptide-major histocompatibility complex complexes: a buried alloreactive mutation subtly alters peptide presentation substantially increasing V(beta) Interactions.
|
| |
J Exp Med, 195,
1175-1186.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
K.Natarajan,
N.Dimasi,
J.Wang,
R.A.Mariuzza,
and
D.H.Margulies
(2002).
Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination.
|
| |
Annu Rev Immunol, 20,
853-885.
|
 |
|
|
|
|
 |
M.G.Rudolph,
J.G.Luz,
and
I.A.Wilson
(2002).
Structural and thermodynamic correlates of T cell signaling.
|
| |
Annu Rev Biophys Biomol Struct, 31,
121-149.
|
 |
|
|
|
|
 |
M.M.Mullen,
K.M.Haan,
R.Longnecker,
and
T.S.Jardetzky
(2002).
Structure of the Epstein-Barr virus gp42 protein bound to the MHC class II receptor HLA-DR1.
|
| |
Mol Cell, 9,
375-385.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.Kogelberg,
and
T.Feizi
(2001).
New structural insights into lectin-type proteins of the immune system.
|
| |
Curr Opin Struct Biol, 11,
635-643.
|
 |
|
|
|
|
 |
S.Radaev,
B.Rostro,
A.G.Brooks,
M.Colonna,
and
P.D.Sun
(2001).
Conformational plasticity revealed by the cocrystal structure of NKG2D and its class I MHC-like ligand ULBP3.
|
| |
Immunity, 15,
1039-1049.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|